For the Quarter Ending September 2024
North America
In Q3 2024, Dimethylacetamide (DMAC) prices in North America experienced an upward trajectory, with the USA observing the most significant price hikes. This growth stemmed from a combination of factors affecting market dynamics, notably supply constraints and heightened demand from critical downstream sectors. Labor strikes and natural disasters played a pivotal role in tightening the supply of DMAC across the region, as these disruptions impacted both production and transportation channels. This scarcity exerted considerable upward pressure on DMAC prices, with manufacturers struggling to maintain supply amid restricted availability.
Adding to the strain, the Pharmaceutical sector, a primary consumer of Dimethylacetamide, witnessed a surge in demand during the quarter. The pharmaceutical industry which depends on DMAC in various applications, placed additional pressure on an already limited supply and further elevated prices. Feedstock prices for Dimethyl Amine and Acetic Acid, both essential inputs in DMAC production, experienced steady growth throughout Q3, driving up production costs and reinforcing bullish sentiment in the DMAC market.
The combination of supply constraints, strong demand from the pharmaceutical industry, and rising feedstock prices created a tight market environment. Consequently, DMAC prices climbed as suppliers adjusted quotations to reflect these challenging conditions, establishing a notably bullish outlook for the US market in Q3.
APAC
The third quarter of 2024 has been characterized by a persistent downward trend in Dimethylacetamide pricing across the APAC region, with notable influences impacting market prices. Factors such as weakened demand from key downstream sectors, particularly the construction and pharmaceutical industries, have contributed significantly to the declining prices. However, the fluctuations in production costs due to mixed feedstock prices, notably Dimethyl Amine and Acetic Acid, have kept pricing pressures on Dimethylacetamide. In China, the market has experienced the most significant price changes, with a -9% decrease compared to the same quarter last year. The correlation between price changes and seasonality has been evident, with a -7% change from the previous quarter in 2024 and a -4% difference between the first and second half of the quarter. The latest quarter-ending price of USD 950/MT of Dimethylacetamide FOB-Nanjing in China reflects the prevailing negative sentiment in the pricing environment, showcasing a consistent decrease in market prices throughout the quarter.
Europe
In Q3 2024, Europe’s Dimethylacetamide (DMAC) market faced a marked decline in prices, reflecting a challenging environment shaped by subdued demand and economic uncertainty. Downstream sectors, especially Pharmaceuticals and Construction, witnessed weakened activity due to ongoing economic pressures and reduced consumer spending, resulting in lower demand for DMAC. This decline in usage across critical sectors created an oversupply situation, which intensified the downward pressure on DMAC prices. Interestingly, feedstock prices for Dimethyl Amine and Acetic Acid, essential raw materials for DMAC production, experienced steady growth during the quarter. Rising costs for these inputs pushed up production expenses, yet producers struggled to transfer these costs to end-users amid the unfavorable market sentiment. Consequently, the disconnect between production costs and selling prices weighed on profitability, compelling market players to offer competitive pricing to stimulate limited demand. The result was a bearish pricing environment for DMAC in Europe, with market sentiment dampened by weak downstream demand and economic challenges despite escalating production costs. This combination of factors underscored the difficulties faced by the European DMAC market in Q3.
For the Quarter Ending June 2024
North America
During Q2 2024, the North American Dimethylacetamide (DMAc) market encountered a downward trend in prices, influenced by several factors that collectively imposed bearish pressure on the market. Despite an increase in prices for upstream raw materials like Dimethyl Amine and Acetic Acid, which typically drive up production costs, the DMAc market did not experience a corresponding rise in prices. Instead, ample inventory levels and subdued demand from crucial downstream sectors such as construction played a more significant role in shaping market dynamics. The availability of excess supply, coupled with diminished consumption, created a scenario where prices softened across the region, even as production costs remained elevated.
The seasonality effects, which often contribute to fluctuations in market prices, were notably overshadowed by the oversupply and slackened demand. The construction sector faced reduced activity levels due to high inflation and economic uncertainties, leading to cautious procurement practices. This conservative approach from downstream sectors further exacerbated the imbalance between supply and demand, reinforcing the downward pressure on prices. As a result, despite seasonal trends that might typically support price increases or stabilization, the overarching market sentiment remained bearish.
Overall, the pricing environment for Dimethylacetamide in North America during Q2 2024 was decisively negative. High inventory levels, coupled with restrained purchasing behavior from downstream sectors, created an environment where prices trended downward. The impact of high inflation and economic caution contributed to a general market bearishness, overshadowing any potential positive influences from rising upstream costs or seasonal demand variations.
APAC
The Dimethylacetamide market in the APAC region experienced a notable decline in prices throughout Q2 2024. This quarter was marked by several significant factors that collectively influenced the market. Unprecedented downpours and severe flooding disrupted supply chains, particularly affecting southern regions. The construction sector, a major downstream consumer of Dimethylacetamide, saw sluggish demand due to these adverse weather conditions. Additionally, stable production costs did not provide any relief, as the prices of feedstocks such as Dimethyl Amine and Acetic Acid remained unchanged. Competitive pressures within the industry further curbed any potential price increments, leading to a consistent downward trajectory. Focusing on China, the country witnessed the most significant price shifts. The overall trend in China was driven by ample inventory levels, moderate to low demand from key sectors such as construction, and disrupted trading activities due to both natural and geopolitical factors. Seasonality also played a role, with traditional holiday periods slowing down market activities. Compared to the previous quarter of 2024, prices fell by 7%, continuing the negative sentiment. The quarter ended with Dimethylacetamide prices settling at USD 1020/MT (FOB-Nanjing). The pricing environment throughout Q2 2024 has been predominantly negative, driven by a confluence of adverse factors, contributing to a sustained decrease in market prices.
Europe
The Dimethylacetamide (DMAc) market in Europe faced a challenging Q2 2024, marked by a persistent decline in prices driven by several key factors. One of the primary contributors to this bearish market sentiment was the subdued demand from the downstream construction sector. Despite the European Central Bank's (ECB) interest rate cut, which aimed to stimulate economic activity and boost consumption, the construction sector failed to show significant improvement. This sector's sluggish performance was a major disappointment as it traditionally drives a substantial portion of the demand for DMAc. The lack of response to economic stimuli highlighted underlying weaknesses in the sector, reflecting broader economic uncertainties and cautious spending patterns. Additionally, high inventory levels added further pressure on the market. With ample supply already available, market participants were hesitant to increase production or engage in aggressive trading activities, choosing instead to align their strategies with the prevailing low demand. Moreover, the overall trends in Q2 2024 were influenced by seasonality factors, which typically bring fluctuations in demand. However, the usual seasonal upticks were notably absent, exacerbating the bearish sentiment in the DMAc market. This absence of increased seasonal demand contributed to a consistent downward trajectory in prices. The stable yet low activity levels across key sectors like construction underscored the lackluster consumption of DMAc. Consequently, market participants had to navigate a negative pricing environment, adjusting their strategies to mitigate losses and manage the high inventory levels. The combined effects of subdued demand, high inventories, and the lack of seasonal demand surges created a challenging market landscape for DMAc in Europe, resulting in persistently declining prices throughout the quarter.
For the Quarter Ending March 2024
North America
In the North American Dimethylacetamide market during the observed period, a downward trajectory was evident, influenced by multiple contributing factors. One significant factor was the accumulated inventories, exacerbating the market's weak condition. However, the demand from the downstream Textile sector was moderate which led to a healthy rate of consumption of the inventories. Moreover, the declining prices of key feedstocks like Dimethyl Amine and Acetic Acid played a pivotal role in reducing the production costs of Dimethylacetamide. This factor further compounded the downward pressure on prices.
According to the Federal Reserve, industrial production in the United States grew in March. However, it experienced a decline at an annual rate during the first quarter of this year. Manufacturing output also saw an uptick in March and was higher compared to the same period last year. Additionally, there was a decline in the production of energy materials. Considering the market dynamics, the market participants responded cautiously, adjusting their ex-quotations downward to stimulate inventory utilization, albeit at the expense of their profit margins.
On the buyers' side, concerns about procurement emerged, leading to restrained purchasing activities aimed at mitigating potential losses and restoring equilibrium in supply and demand. In summary, the Dimethylacetamide market in North America experienced a decline primarily due to inventory accumulation along with the moderate demand from the downstream sector and reduced production costs driven by falling feedstock prices.
APAC
In Q1 2024, Dimethylacetamide prices in the APAC region experienced a consistent decrease. Several factors contributed to this downward trend, including sluggish demand from downstream industries and ample inventory levels. The prices of feedstocks such as Dimethyl Amine and Acetic Acid also remained stable, resulting in a maintained production cost for Dimethylacetamide. The overall market sentiment was bearish, with market participants cautious in their procurement behavior. China, in particular, witnessed the maximum price changes in Dimethylacetamide during this period. The overall trend in China reflected the same decreasing sentiment seen in the APAC region. The market was affected by factors such as a weakening property crisis, declining prices, and sluggish demand from the downstream Textile industry. Despite the end of the Lunar New Year and ongoing snowstorms, the prices of Dimethylacetamide in China declined. Compared to the same quarter last year, Dimethylacetamide prices in Q1 2024 decreased by 2%. The quarter-on-quarter percentage change recorded a decline of 7%. Additionally, there was a 6% decrease in prices between the first and second half of the quarter. Overall, the pricing environment for Dimethylacetamide in the APAC region, particularly in China, has been negative, with a consistent decrease in prices throughout Q1 2024.
Europe
The Dimethylacetamide market in Europe showcased a declining pattern due to several factors that contributed to the downward trend of the commodity. The lower demand for Dimethylacetamide from the downstream Textile sectors resulted in the slow consumption rate of the commodity which resulted in the pilling of the inventories and therefore, contributed to the weak market scenario for the commodity. In terms of the feedstock market, the prices of Dimethyl Amine and Acetic Acid were declining which resulted in the lower production cost of the commodity. Additionally, the ongoing Farmer’s Protest disrupted the supply chain resulting in the disrupted supply and demand equilibrium. The market players were cautious and therefore, reduced their ex-quotation at the cost of their marginal profits so that the stocked-up inventories could be utilized primarily. However, the buyers were concerned about their procurement as well, since they limited their procurement activities to prevent potential losses and with the hope of attaining the supply and demand equilibrium. It can be concluded that Dimethylacetamide followed a downward trend due to sluggish demand, stockpiling of the inventories, and lowered production cost of the commodity.
For the Quarter Ending December 2023
North America
During the fourth quarter ending in December 2023, the US market prices of Dimethylacetamide showcased bullishness in its trend. The market players attributed this to the heightened demand from the downstream textile and polymer manufacturing sectors along with the low supplies of the product. In terms of the upstream market, the prices of dimethylamine supported the prices of the commodity, however, acetic acid followed the opposite trend.
Despite this, the prices of the commodity followed an upward trend. This market situation gave the market players to play in their terms which led to the increase in ex-quotations, to enhance their profit margins along with the sales. Additionally, the buyers went toward bulk procurement to attain the supply and demand equilibrium.
Furthermore, considering the market situation the producers raised their production rate to fill the gap required to attain the smoothness of the supply chain. An increase in the demand from the downstream textile and polymer manufacturing sector resulted in the increased consumption rate of the existing inventories creating the need to restock the storage facilities.
APAC
The APAC Dimethylacetamide market in the fourth quarter of 2023 witnessed a bullish trend with low supply and high demand. The market was affected by various factors such as low supply over high demand. One of the major players in the market, China, observed a price incline of approximately 8% towards the end of the quarter, with the latest price of Dimethylacetamide FOB-Nanjing standing at USD 1152/MT. However, the market remained bullish with insufficient product availability amid strong market sentiments and a potential decrease in supply due to manufacturers reducing their production capacity. Additionally, an increase in energy prices may further surge the overall production cost of the product. A primary reason for the market fluctuations was the supply-demand imbalance driven by heightened demand from downstream industries, including textiles, pharmaceuticals, and the coating sector. The market witnessed no plant shutdown during the quarter. In response to this market condition, traders adjusted their ex-quotations, marginally raising prices to improve their profit margins.
Europe
In the European market, the prices of Dimethylacetamide recorded an upward trend showcasing the bullishness in the market situation of the commodity. This upward movement was attributed to heightened demand from the textile and polymer manufacturing sectors downstream, coupled with limited product supplies. Although the prices of dimethylamine, an upstream component, provided support, acetic acid exhibited an opposing trend. Despite this, the overall trajectory for dimethylacetamide prices remained upward. Market dynamics favored players, allowing them to adjust ex-quotations for increased profitability and sales. Buyers responded with bulk procurement to achieve supply and demand equilibrium. Producers responded to market conditions by elevating production rates to address supply chain smoothness. Rising demand in the textile and polymer manufacturing sector led to increased consumption of existing inventories, prompting the need for restocking storage facilities.
For the Quarter Ending September 2023
North America
In the United States market, the Dimethylacetamide (DMA) sector experienced mixed sentiments during the third quarter of 2023. As the quarter commenced, the market witnessed a decrement in its pricing. This price decline was chiefly attributable to sluggish demand from key downstream industries. Notably, sectors such as Textiles and Adhesives, traditionally substantial consumers of Dimethylacetamide, displayed weakened demand both domestically and abroad. Despite an upward trend in feedstock Dimethylamine prices, persistent weak demand dominated market fundamentals, resulting in pricing remaining at the lower end. As the second month of Q3 unfolded, Dimethylacetamide prices in the United States market continued to decrease due to the absence of significant alterations in factors influencing final prices. As we approached the end of Q3, the U.S. DMA market observed a significant price increase, primarily propelled by heightened demand from downstream industries, with specific emphasis on the Pharmaceutical and Electronics & Semiconductor manufacturing sectors. This surge in demand coincided with a constrained supply situation, further exacerbated by material availability limitations, leading to disruptions in the DMA supply chain. Additionally, the rising cost of a crucial feedstock, Dimethylamine, contributed to the upward price trend.
APAC
In the Asia-Pacific region, the market of Dimethylacetamide (DMA) displayed mixed sentiments during the third quarter of 2023. At the beginning of the quarter, the market of Dimethylacetamide witnessed decrement in its pricing. This downward trajectory can be attributed to subdued demand from its major downstream industries. Notably, sectors such as Textiles and Adhesive which have traditionally been significant consumers of Dimethylacetamide, have exhibited weakened demand from the local as well as from the overseas market. However, the feedstock Dimethylamine prices are showing upward trend, but continuous weak demand dominated the market fundaments and kept the prices at lower end. As the second month of Q3 unfolded, Dimethylacetamide prices in the Chinese market continued to decrease due to the absence of significant changes in the factors affecting final prices. Further moving toward the end of the Q3, Chinese (DMA) market has witnessed a significant increase in prices, primarily driven by heightened demand from downstream industries, with particular emphasis on the Pharmaceutical and, Electronics & semiconductor manufacturing sectors. This surge in demand has occurred alongside a tightened supply situation, exacerbated by constraints in material availability, leading to disruptions in the DMA supply chain. Furthermore, the escalating cost of a major feedstock Dimethylamine has contributed to the price upturn. The increase of 0.3 percentage points in the new orders index from the previous month indicates a growing demand in the manufacturing market.
Europe
In the European market, the Dimethylacetamide (DMA) sector displayed a consistent declining trend during the third quarter of 2023, supported by a weak Purchasing Managers' Index (PMI) and lingering recession fears. As the quarter commenced, the market witnessed a decrement in its pricing. This downward trajectory was primarily linked to subdued demand from key downstream industries. Notably, sectors such as Textiles and Adhesives, which have traditionally been significant consumers of Dimethylacetamide, exhibited weakened demand both within the European market and from international trade partners. The impact of a feeble PMI index and concerns over a looming recession further added to the downward pressure on the DMA market. These economic factors cast a shadow on market dynamics and exacerbated the challenges faced by manufacturers and suppliers in the European region. Despite an upward trend in feedstock Dimethylamine prices, the combination of a declining PMI and recessionary fears compounded the downward pricing trend. Market participants exercised caution, adjusting their strategies to navigate this complex economic landscape. The weak PMI and recession concerns have made it challenging for the DMA market to regain its footing, with the price trend reflecting these uncertainties throughout the quarter.
For the Quarter Ending June 2023
North America
In the US market, the price of Dimethylacetamide experienced a mixed trend during the second quarter of 2023. The market sentiments fluctuated based on various factors impacting demand and supply dynamics. At the beginning of the quarter, the Dimethylacetamide market witnessed a surge in price trends. This growth can be attributed to the surge in demand for Dimethylacetamide from the Solvent and Adhesive sectors. Additionally, favorable market conditions and stable economic growth played a role in the upward trend. Moving to the month of May, the US market remained stable during this period, and the was due consistent demand for material across the region. However, in June, the Dimethylacetamide market experienced a declining trend. The unbroken declining downstream demand from the Adhesive businesses kept the buyers on edge with high product records. The overall declining price trend amid uncertain economic conditions coupled with the rising inflation rate. Furthermore, the ample practicality of material at a lower price from the overseas market provokes the local mills to reduce their offer prices.
Europe
In the European region, the market of Dimethylacetamide displayed mixed sentiments during the second quarter of 2023. In the month of April, the Dimethylacetamide market witnessed a surge in price trend on account of high demand from the major downstream solvent and adhesive industry. However, in the month of April, increased trading activities and inventory stockpiling helped to mitigate supply shortages and meet the requirement of downstream industries. As a result, during May, market participants adjusted their procurement strategies to align with stabilized demand with normalized market condition, with the market remaining stable during the month. However, in the last month, according to market analysis, due to competitive market conditions and large stock volumes, market players maintained a gloomy price momentum due to weak demand fundamentals and subdued spot activity across the globe. Meanwhile, continuous dipping demand from the downstream Solvent and Adhesive industries preserved traders on side coats to procure heavy orders. Additionally, economic uncertainty and recession fear governed the market sentiments within the region.
APAC
In the Asia-Pacific region, the market of Dimethylacetamide displayed mixed sentiments during the second quarter of 2023. At the beginning of the quarter, the market of Dimethylacetamide witnessed a surge in price trend. This turnaround was prompted by a rise in the consumption rate of Dimethylacetamide material from the major downstream Solvent and Adhesive industries. However, in the past last month of the second quarter, the Dimethylacetamide market continued to follow a declining price trajectory. The spot market continued to observe a slower pace; despite the lower spot price offers, petitions from the enterprises remained low. Additionally, the manufacturers were seen under pressure with a declining demand situation and were found to claim lower consumption rates of Dimethylacetamide from the associated downstream Solvent and Adhesive businesses. A slump in purchasing activities of Dimethylacetamide was observed as the demand recovery fell short of expectations. Overall consumption showed a deep contraction and failed to regain momentum amid Weak demand from downstream Solvent and Adhesive industries. However, in the second quarter of 2023, there was not a major increment in the price of Dimethylacetamide FOB-Nanjing in the Asian region with it, showcasing a minute increment of (0.8%) during the entire second quarter.
For the Quarter Ending March 2023
North America
In the USA, the major Dimethylacetamide refiners reduce their production rate due to weak regional sales and deteriorating market fundamentals. In terms of the upstream market, Acetic Acid was increasingly oversupplied, with high product availability and lackluster spot price discussions. Export prices of Dimethylacetamide faced a Southward trend with lower trading fundamentals. Seasonal low-driving trading activity from the downstream solvent industries also hampered the price trend. Deterred market essentials and restricted exports to South America and Canada make it challenging for the producers to raise the costs further. The supply of Dimethylacetamide exceeds the demand, and the suppliers remained reluctant to increase the prices for the domestic and overseas markets.
Asia Pacific
This quarter, the Dimethylacetamide market showcases a bearish price trend in the wake of lackluster demand and the high declining interest of traders to purchase the cargoes in bulk. The offers and bids of Dimethylacetamide among suppliers from overseas suppliers remain affected by limited market fundamentals and continuous increases in product inventories. The demand for Dimethylacetamide from the downstream solvent industries remains bearish with sparse trading fundamentals. In China, the price of Dimethylacetamide during Feb 2023 slipped to USD 1154/ton FOB Nanjing. Solvent and pharma enterprises stay impacted because of low buying regard from the end user. In Q1 2023, the interest began to fall with frail market essentials in the Asian market.
Europe
In Q1 2023, the Dimethylacetamide prices in the European market showcased a bearish price trend in the wake of low market demand and high product inventories. In the feedstock Acetic Acid market, costs slumped with oversupplies and lower offerings for new stocks. Dimethylacetamide prices slipped due to deteriorating demand and an outflow of cargo from Germany, the Netherlands, and Belgium to the global market. Narrowing profit margins and constraints in demand forced the producers to decrease the prices of Dimethylacetamide for domestic and overseas providers. Cost support was weakened by the seller end with the burden to clear the existing inventories.
For the Quarter Ending December 2022
North America
In Q4 2022, the Dimethylacetamide market in North America was observed to be bearish amid weak trading activities and weak market fundamentals. Low purchasing esteem and deteriorating demand resulted in declination in the price trend. The downstream solvent market was also affected by low purchases and feeble demand from the consumer's end. Suppliers have sufficient stocks among the enterprises to fulfill the demand from the end-user enterprises. Trade volume among the storage units surged, and high product inventories forced the producers to offer the cargo at discounts. The demand for Dimethylacetamide from the downstream solvent and adhesive industries ended up on a bearish note with cautiously operating ventures.
Asia Pacific
This quarter, the trading fundamentals of Dimethylacetamide in China slumped compared with the previous one. However, the price increased in Oct with low product inventories. The constricted supply of products coupled with the increment in trading activities affected the region's operating rate of Dimethylacetamide, leading the prices to inflate in the market. However, in Nov, falling demand for Dimethylacetamide from the downstream enterprises and weak trading fundamentals helped the prices to drop. The Dimethylacetamide market was sluggish due to the low market sentiment and limited trading to oversupplies suppliers. In China, the price of Dimethylacetamide in China slipped to USD 1303/ton FOB in Nanjing.
Europe
In Q4 2022, with declining trading fundamentals due to weak domestic demand, the significant producer offered discounts on bulk purchases. With cautiously operating manufacturing units, demand for Dimethylacetamide in the downstream solvent industry stays feeble. There was weak price support with low buying activities in the region. Ease in energy values and low production rate among the undertakings bring about oversupplies constraining the makers from clearing their current inventories. Trading of Dimethylacetamide in the European region was weak, and declining freight charges made the import prices bearish. Towards the end of the quarter, the price quotations for the end user industries declined, and the suppliers remained skeptical about declining the price further due to declining profit margin and revenue.
For the Quarter Ending September 2022
North America
In Q3 2022, the market of Dimethylacetamide declined in the USA, prompted by weak market fundamentals and sufficient product availability. In terms of the feedstock market, Dimethyl Amine prices also faced South along with production cuts among the manufacturers as a result of capacity additions in the United States. The market was also affected by the expansion of supply. Conversely, the weak North American demand impacted European trade, with the oversupply of chemicals in European business sectors. The interest from the downstream Solvent industries has been frail. The contract prices of Dimethylacetamide for the American market also declined due to weak purchasing and oversupplies of products.
Asia Pacific
This quarter, the price of Dimethylacetamide declined in the succeeding months due to adequate supply and low demand from the downstream industries. In China, the cost of Dimethylacetamide during September fell to USD 1520/ton FOB Nanjing. Due to the weak market sentiment and massive stockpiling of inventories, the market price for Dimethylacetamide crashed in the China market as the sellers accepted a lower cost to clear out stocks to start production for the next supply. The demand for Dimethylacetamide from the downstream solvent industry remained bearish, with low demand for the consumer's end. Exports from China to other Asian regions decreased due to abundant supply.
Europe
In Q3 2022, the market of Dimethylacetamide stabilized on the upper side due to rising utility and energy values in the region. The inadequate stock of Dimethylacetamide and its feedstock Dimethyl Amine in the European market made it difficult to meet the necessities in their domestic market. Regional demand for products remains tepid, which elevated the prices. However, the need for Dimethylacetamide from overseas declined due to oversupplies of products and weak market dynamics. In the domestic market, the demand slowed toward the end of the quarter due to sufficient stock and lower purchasing activities.
For the Quarter Ending June 2022
North America
In Q2 2022, the price of Dimethylacetamide surged with the increasing cost of feedstock Acetic Acid and Dimethyl amine in the US. Prices surged with bullish crude and Natural Gas prices. Accelerating demand for downstream solvent and adhesive and the stoppage of all businesses between Russia and the USA following the ongoing conflict have caused the prices to become firmer. The price trend has risen steadily with healthy demand and limited product supply. Although US chemical production gradually resumed, accessible amounts for export to Europe remained limited. Turnaround of manufacturing units of feedstock Acetic Acid in this quarter had cut the production rate resulting in a price hike.
Asia Pacific region
In Q2 2022, the price of Dimethylaceatamide slipped in April 2022 due to weak demand from downstream ventures and fluctuations in feedstock prices. However, in May and June, the prices surged with a steep inclination of purchasing and strong market sentiments. Product's Dimethylacetamide exports have been under a heavy strain from sluggish resin demand during the last few months. In April, record-high inflation coupled with tight liquidity and disappointing seasonal factors kept prices on a bearish note. Exports of Dimethylacetamide from India and China to other Asian regions surged in the second half of the quarter, maintaining a gap between supply and demand, resulting in such a price hike.
Europe
The demand for Dimethylacetamide was driven by an expansion in solvent and adhesive demand in the domestic market of Europe. The industry was combined, with a couple of huge players controlling an enormous piece of the overall market; subsequently, product makers' essential procedure was to fulfill the requirement from the consumer's end. All through the second quarter of 2022, the European market for feedstock Acetic Acid stayed positive. This change in market sentiments was connected with Europe's drawn-out energy crisis, which brought about lower production rates at manufacturing units. The downstream solvent and adhesive industries didn't catch up with the end users' requirements, forcing them to increase the prices of their products. Because of the expanded interest from the downstream business, Dimethylacetamide costs stayed tepid during the second quarter of 2022.
For the Quarter Ending March 2022
North America
In Q1 2022, the cost of Dimethylacetamide slipped all through the quarter in USA as a result of weak Acetic acid market and deterred market sentiments. Further deteriorating demand is set to continue as operating rates for significant derivative portions including adhesive and dyes endeavours were apparently high in the U.S and gave fragile perceivability on prices with the succeeding month of the quarter. We've additionally seen first the tepid visibility in the medium-term pricing environment kept on expecting adequate feedstock methanol inventories with feeble market essentials decreasing the costs. Exports to European Nations were also affected as the oversupplies of product in the overseas affected the expenses. In this quarter, the cost of Dimethylacetamide in January observed to be USD 3670/ton CFR Texas.
Asia Pacific
In Q1 2022, the cost of Dimethylacetamide remained stable with tepid market sentiments in the domestic market of India. In February 2022, The Bureau of Indian Standards (BIS) had bound to compel new quality control rules for Methanol imports which make issues for the vendors to meet the specifications. Underlying market opinions for Naphtha stays weak on determined worry over offset olefin and aromatic margins. Usage of Dimethylacetamide in adhesive ventures was moreover extended with accelerating demand from the end users. In India, the expense of Dimethylacetamide towards the quarter end was assessed to be USD 2555/ton Ex-Mumbai. In China, the market remained feeble, and the Commodity Exchange prospects similarly decreased as the interest from downstream endeavours was not consistent.
Europe
European Dimethylacetamide market remained on the lower side with declining demand in Q1 2022 when compared with previous quarter. Demand remained frail and the stockpile was adequate which brought such expense design. Major downstream derivative producer organizations had kept up with costs on their product regardless of slow interest and accumulation of inventories. Feedstock Acetic Acid showed level of frail trading environment and producers had moved from negotiation mechanism and rather decreased the expenses on account of sufficient accessibility and lower production cost. Downstream adhesive industries had in like manner slipped, and the demand/supply harmony became unstable. In Germany, the price of Dimethylacetamide during January were observed to be USD 4025/ton FD Hamburg.
For the Quarter Ending December 2021
North America
High raw material cost amid stable offtakes from the domestic downstream sectors, pushed up the prices of several commodities including Dimethylacetamide (DMAC) across the region. Pharma sector of USA showcased overall stability during this timeframe, while major pharma intermediates and raw material climbed up on the back of inflationary pressure induced due to high upstream values and high domestic consumption. In addition, export demand also remained buoyant from European market, as rebound in regional consumption and soaring input cost compelled European traders to look forward for cheaper imports from other regions. Conclusively, DMAC price remained buoyant throughout the quarter while showcasing marginal fluctuations of around USD 80-120/MT during Q4 2021.
Asia
On the back of soaring upstream cost, drastic change in Dimethylacetamide (DMAC) prices has been observed throughout the quarter. Several downstream consumers from paints and pharma sector were very cautious about this steep inclination in price trend of the product. Furthermore, after government decision on removing charges from keeping shipping container for more than waiting time at port down, exporters were able to export more cargoes than before, and thus export activities improved respectively from India. DMAC price revolved around USD 2180/MT during December in India. Meanwhile, Chinese market remained cautious about rising cost of several commodities including DMAC in the country. On the other hand, production contains across the country, due to soaring energy cost and dual energy policy related restrictions.
Europe
Rising raw material cost caused concerns for major European players as the domestic demand for the pharma products remained modest to form while consumption as well as well regional trade activities were high in the meantime. In addition, UK market heard facing difficulties in domestic transport due to shortage of labour force. Furthermore, exorbitant surge in natural gas value also remained a matter of concern for regional players, as upstream values surging in uncontrolled manner. Thus, between this market turmoil, DMAC price maintained overall firmness throughout Q4 2021 in Europe.
For the Quarter Ending September 2021
North America
The prices of Dimethylacetamide rose effectively in the North American region during Q3 2021 owing to strong demand from the downstream agrochemicals, pharmaceuticals, and synthetic fibers (Polyacrylonitrile and polyurethane) markets. In terms of supply, it has remained tight throughout Q3 due to a continuous rise in the prices of upstream feedstock Acetic Acid. Limited availability of raw materials and increased shipping charges and high freight costs are some of the factors that resulted in the upward momentum of dimethylacetamide prices across the region in this quarter.
Asia Pacific
The domestic Asian Market witnessed an upward trajectory in the third quarter of 2021. In India, the prices of dimethylacetamide have been on a constant rise throughout the quarter due to the strong demand from the agrochemicals, pharmaceuticals, and textile industries. The supply has been disrupted in Q3 due to consistently increased prices of upstream acetic acid in the region. Dimethylacetamide FOB Mumbai (India) prices shot up from USD 1899/MT to USD 2037/MT from July to September. High freight charges and constrained material availability have further caused an increment in the pricing trend of dimethylacetamide in Q3 2021.
Europe
The market trend of Dimethylacetamide witnessed an upward trajectory across the European region in Q3 of 2021. In terms of demand, offtakes from the downstream pharmaceutical and agrochemical sector improved during this quarter. Taking support from soaring feedstock prices and tight availability of raw materials amidst stable to firm demand, prices of Dimethylacetamide significantly increased in Europe in Q3.
